US FDA found no increased risk of suicidal behaviour or ideation linked to GLP-1s (LLY, NOVOB DC), according to Bloomberg; has asked companies to remove warnings about potential risk from the medicines' labels
Importance
Level 1
#FDA#EQUITIES#EU SESSION#US SESSION#PHARMACEUTICALS#PHARMACEUTICALS (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#S&P 500 INDEX#ELI LILLY AND CO#LLY#GLOBAL EQUITIES